APW
COCP icon

Allied Private Wealth’s Cocrystal Pharma COCP Stock Holding History

Allied Private Wealth’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31 Buy
+32
New +$39 ﹤0.01% 894

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Allied Private Wealth's COCP Position: Q2 2026 in Review

Allied Private Wealth opened a new position in Cocrystal Pharma (COCP) in Q2 2026: 32 shares worth $31. The stake represents ﹤0.01% of the portfolio and ranks #894 among its holdings.

27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • Allied Private Wealth held 32 shares of Cocrystal Pharma worth $31 as of Q2 2026.
  • Cocrystal Pharma was a new Allied Private Wealth position in Q2 2026.
  • Cocrystal Pharma made up ﹤0.01% of Allied Private Wealth's portfolio in Q2 2026, its #894 holding.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Allied Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.